These agents differ in structure and are generally classified ... Full size table Regarding the anti-PD-1 antibodies, the fully human nivolumab (Bristol-Myers Squibb) and the humanised ...
The patient treated was determined to have progressive disease following a two-month "run -in" period of the anti-PD-1 drug Nivolumab ... rates to anti-PD-1 antibodies. In preclinical studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback